Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-007739
Filing Date
2010-02-09
Accepted
2010-02-09 16:40:05
Documents
1
Period of Report
2010-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd265237.html 4  
1 FORM 4 rrd265237.xml 4 3735
  Complete submission text file 0001181431-10-007739.txt   5719
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address
Grais Linda S (Reporting) CIK: 0001413306 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 10584856